99 related articles for article (PubMed ID: 12844439)
21. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
Catchpoole DR; Stewart BW
Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925
[TBL] [Abstract][Full Text] [Related]
22. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
23. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.
Tilby MJ; Johnson C; Knox RJ; Cordell J; Roberts JJ; Dean CJ
Cancer Res; 1991 Jan; 51(1):123-9. PubMed ID: 1703029
[TBL] [Abstract][Full Text] [Related]
24. [A new anticancer drug sensitivity test using the microplate culture and surviving tumor cell staining method].
Hongo T; Mizuno Y; Haraguchi S; Yoshida TO
Gan To Kagaku Ryoho; 1986 Feb; 13(2):247-54. PubMed ID: 2418790
[TBL] [Abstract][Full Text] [Related]
25. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
26. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation.
Koceva-Chyła A; Jedrzejczak M; Skierski J; Kania K; Jóźwiak Z
Apoptosis; 2005 Dec; 10(6):1497-514. PubMed ID: 16215684
[TBL] [Abstract][Full Text] [Related]
28. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
29. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
30. Camptothecin induces DNA strand breaks and is cytotoxic in stimulated normal lymphocytes.
Yamauchi T; Yoshida A; Ueda T
Oncol Rep; 2011 Feb; 25(2):347-52. PubMed ID: 21165573
[TBL] [Abstract][Full Text] [Related]
31. Rapid simultaneous determination of apoptosis, necrosis, and viability in sulfur mustard exposed HaCaT cell cultures.
Heinrich A; Balszuweit F; Thiermann H; Kehe K
Toxicol Lett; 2009 Dec; 191(2-3):260-7. PubMed ID: 19766703
[TBL] [Abstract][Full Text] [Related]
32. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
Jeremić B; Sibamoto J; Abe M
Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
[TBL] [Abstract][Full Text] [Related]
33. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
Teicher BA; Holden SA; al-Achi A; Herman TS
Cancer Res; 1990 Jun; 50(11):3339-44. PubMed ID: 2334928
[TBL] [Abstract][Full Text] [Related]
34. [Anticancer drug induced sister chromatid exchange and correlation to cell survival in human brain tumor cells].
Aida T; Bodell WJ
No To Shinkei; 1987 Mar; 39(3):235-41. PubMed ID: 3472531
[TBL] [Abstract][Full Text] [Related]
35. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations.
Meurette O; Lefeuvre-Orfila L; Rebillard A; Lagadic-Gossmann D; Dimanche-Boitrel MT
Clin Cancer Res; 2005 Apr; 11(8):3075-83. PubMed ID: 15837763
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis-based drug screening and detection of selective toxicity to cancer cells.
Frankfurt OS; Krishan A
Anticancer Drugs; 2003 Aug; 14(7):555-61. PubMed ID: 12960740
[TBL] [Abstract][Full Text] [Related]
37. A synergistic increase of apoptosis utilizing Fas antigen expression induced by low doses of anticancer drug.
Akiyama H; Ino T; Tokunaga E; Katsuda I; Ezaki K
Rinsho Byori; 2003 Aug; 51(8):733-9. PubMed ID: 13677932
[TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of a novel recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand.
Fang F; Wang AP; Yang SF
Acta Pharmacol Sin; 2005 Nov; 26(11):1373-81. PubMed ID: 16225761
[TBL] [Abstract][Full Text] [Related]
39. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
40. [Apoptosis of B lymphocytic leukemia induced by anticancer drugs and their cell cycle specificity].
Sun X; Saeki K; Masahito T
Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):25-7. PubMed ID: 10921050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
